Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Prima BioMed Ltd (IMMP) had Operating Cash Flow per Share of $-0.28 for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
$6.69M |
|
$-39.78M |
|
-- |
|
$6.69M |
|
$45.39M |
|
$-38.70M |
|
$-1.08M |
|
$-39.78M |
|
$-39.78M |
|
$-39.78M |
|
$-39.78M |
|
$-39.78M |
|
$-39.78M |
|
$-38.70M |
|
$-37.15M |
|
145.58M |
|
145.58M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$96.56M |
|
$0.04M |
|
$5.11M |
|
$101.66M |
|
$8.26M |
|
-- |
|
$0.38M |
|
$8.64M |
|
$93.02M |
|
$88.36M |
|
$93.02M |
|
146.04M |
|
| Cash Flow Statement Financials | |
$-40.18M |
|
$-24.95M |
|
$-0.34M |
|
$104.78M |
|
$43.65M |
|
$-61.12M |
|
$0.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.69 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
100.00% |
|
-578.44% |
|
-578.44% |
|
-555.31% |
|
-594.64% |
|
-594.64% |
|
$-40.21M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
1.05 |
|
348.64 |
|
-42.77% |
|
-45.03% |
|
-39.13% |
|
-42.77% |
|
$0.64 |
|
$-0.28 |
|
|
Operating Cash Flow per Share |
$-0.28 |